Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 8/20 | 1.00 |
| ▸ | KMT2A | Q03164 | 8/20 | 1.00 |
| ▸ | NPC1 | O15118 | 5/20 | 0.79 |
| ▸ | MAPT | P10636 | 4/20 | 0.79 |
| ▸ | RAB9A | P51151 | 4/20 | 0.79 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.79 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.79 |
| ▸ | MYOC | Q99972 | 1/20 | 0.79 |
| ▸ | LMNA | P02545 | 2/20 | 0.77 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.77 |
| ▸ | CA12 | O43570 | 1/20 | 0.66 |
| ▸ | CA1 | P00915 | 1/20 | 0.66 |
| ▸ | CA2 | P00918 | 1/20 | 0.66 |
| ▸ | CA9 | Q16790 | 1/20 | 0.66 |
| ▸ | PTGES | O14684 | 1/20 | 0.65 |
| ▸ | TGM2 | P21980 | 1/20 | 0.65 |
| ▸ | POLB | P06746 | 2/20 | 0.64 |
| ▸ | APEX1 | P27695 | 1/20 | 0.64 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.63 |
| ▸ | NAMPT | P43490 | 1/20 | 0.62 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6302157 | 1.00 | MEN1 (1.00) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL6302417 | 0.94 | MEN1 (0.89) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL11055960 | 0.92 | MEN1 (0.85) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL18825691 | 0.91 | MEN1 (0.82) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL4115432 | 0.91 | MEN1 (0.82) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL1311708 | 0.91 | MEN1 (0.82) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL16005844 | 0.90 | MEN1 (0.81) | MEN1KMT2ANPC1MAPTRAB9A | |
| Diphenylurea SCHEMBL27302793 | 0.90 | MEN1 (0.81) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL6939392 | 0.89 | MEN1 (0.79) | MEN1KMT2ANPC1MAPTRAB9A | |
| SCHEMBL3460442 | 0.89 | MEN1 (0.79) | MEN1KMT2ANPC1MAPTRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 168 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114671783-A | Preparation method of 4, 4' -dinitro diphenyl urea | 浙江工业大学 | 2022-06-28 | — | — | CN | claimed |
| US-20080221214-A1 | Process for the preparation of \"Urchym\" a urease and alpha-chymotrypsin enzyme inhibitory drug | PERVEEN SHAHNAZ | 2008-09-11 | — | — | US | claimed |
| WO-2006060774-A2 | AGENTS THAT INHIBIT FLAVIVIRUS REPLICATION AND USES THEREOF | BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-06-08 | — | — | WO | claimed |
| US-6465194-B2 | HYBRIDOMA CELL LINE | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE | 2002-10-15 | — | — | US | claimed |
| US-20010039332-A1 | Monoclonal antibodies to 4,4'-dinitrocarbanilide and a method for analyzing for the drug nicarbazin | AGRICULTURE, UNITED STATES OF AMERICA, THE, AS REPRESENTED BY THE SECRETARY | 2001-11-08 | — | — | US | claimed |
| US-5552386-A | COMPOUNDS FOR BACTERICIDES OR ANTIPROTOZOA AGENTS | ELI LILLY AND COMPANY (US) | 1996-09-03 | — | — | US | claimed |
| EP-0341019-B1 | POLYETHER ANTIBIOTIC | ELI LILLY AND COMPANY (US) | 1993-01-13 | — | — | EP | claimed |
| EP-0184291-B1 | POLYETHER ANTIBIOTIC A80190 | ELI LILLY AND COMPANY (US) | 1992-05-27 | — | — | EP | claimed |
| EP-0422818-A1 | New polyether antibiotic | ELI LILLY AND COMPANY (US) | 1991-04-17 | — | — | EP | claimed |
| EP-0209971-B1 | POLYETHER ANTIBIOTIC AND PROCESS FOR ITS PRODUCTION | ELI LILLY AND COMPANY (US) | 1991-03-06 | — | — | EP | claimed |
| EP-0341019-A2 | Polyether antibiotic | ELI LILLY AND COMPANY (US) | 1989-11-08 | — | — | EP | claimed |
| US-4824863-A | POLYETHER ANTIBIOTIC, FEEDS | ELI LILLY AND COMPANY (US) | 1989-04-25 | — | — | US | claimed |
| EP-0209971-A1 | Polyether antibiotic and process for its production | ELI LILLY AND COMPANY (US) | 1987-01-28 | — | — | EP | claimed |
| EP-0184291-A2 | Polyether antibiotic A80190 | ELI LILLY AND COMPANY (US) | 1986-06-11 | — | — | EP | claimed |
| US-4582822-A | ANIMAL FEED ADDITIVES | ELI LILLY AND COMPANY (US) | 1986-04-15 | — | — | US | claimed |
| US-4218438-A | POULTRY FEED | ELI LILLY AND COMPANY (US) | 1980-08-19 | — | — | US | claimed |
| US-3957997-A | Anticoccidial complexes of 4,4'-dinitrocarbanilides | MERCK & CO., INC. (US) | 1976-05-18 | — | — | US | claimed |
| US-12606923-B2 | Acid-free pyrolytic synthesis of M-N-C catalyst | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2026-04-21 | — | — | US | disclosed |
| US-3957997-A | Anticoccidial complexes of 4,4'-dinitrocarbanilides | MERCK & CO., INC. (US) | 1976-05-18 | — | — | US | disclosed |
| US-3926935-A | Anticoccidial complexes | MERCK & CO INC | 1975-12-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010039332-A1 | Monoclonal antibodies to 4,4'-dinitrocarbanilide and a method for analyzing for the drug nicarbazin | NRDC, NDC1, NFATC1 | MEN1 2005/4885KMT2A 3023/4885NPC1 2882/4885 |
| US-12606923-B2 | Acid-free pyrolytic synthesis of M-N-C catalyst | LMNA, MNS1, FLNB | MEN1 12/4885KMT2A 2118/4885NPC1 1418/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.